Morishima, Yuto
Ueno, Yuji https://orcid.org/0000-0002-8617-3695
Satake, Akane
Fukao, Toko
Tsuchiya, Mai
Hata, Takanori
Ogawa, Tatsuyuki
Oishi, Naoki
Nakajima, Sho
Hirata, Shuji
Shindo, Kazumasa
Takiyama, Yoshihisa
Article History
Received: 13 November 2022
Accepted: 10 February 2023
First Online: 23 February 2023
Declarations
:
: YU received lecture fees from OHARA Pharmaceutical Co., Ltd., and research funds from Bristol-Myers Squibb. The other authors declare no potential conflicts of interest.
: Not applicable.
: Written, informed consent was obtained from the patient included in the study.